This article analyzes the formation and development of a pharmaceutical safety system in the Russian Federation, which was designed to protect the population and health organizations from threats arising in the production, distribution and consumption of pharmaceuticals. The most difficult period was 1991–1998, which was characterized by a sharp decline in the pharmaceutical industry’s economic potential in connection with the transition to new, market-based management mechanisms and the lack of an adequate regulatory framework for pharmaceutical management